Unmitigated Prejudice or Simple Negligence? The impact of biomedicine and EBM on pandemic influenza public policy Pharmaceuticals and Global Health: Inequalities.

Slides:

Advertisements

Similar presentations

Presentation of ECDC, modelling networks and data availability

Advertisements

Introduction to Pandemic Influenza

Highly Pathogenic Avian Influenza IN EGYPT Presentation by Prof. Dr. Hamed Samaha CVO, GOVS HPAI Technical Meeting Rome, June.

Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.

U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”

Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.

Outbreak Alert and Response Systems: a review February 2004 Ayana Yeneabat, MD, MPH Epidemiologist, WHO.

1 Allocation of Ventilators in an Influenza Pandemic Statewide Videoconference March 16, 2007 Pandemic Influenza Preparedness Planning Guthrie Birkhead,

Global Vaccines 202X : Access, Equity, Ethics Panel discussion: Pandemic Influenza Preparedness Framework for the sharing of Influenza Viruses and Access.

1 PUBLIC - PRIVATE PARTNERSHIP FOR AVIAN INFLUENZA CONTROL AND PANDEMIC PREPAREDNESS Presented by Bayu Krisnamurthi Indonesia National Committee for Avian.

1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.

Avian Influenza and Pandemic Preparedness in Thailand Department of Disease Control Ministry of Public Health Thailand.

CANADIAN DIVISION Pandemic Planning Update H1N1 Flu Virus (Human Swine Influenza) May 2009 Group Benefits.

Melissa House, Ph.D.: Public Health Walden University PUBH Instructor: Dr. Robert Marino Spring Qtr, 2011 D ISASTER P REPAREDNESS P ANDEMIC I NFLUENZA.

OIC-SHPA & Vaccines Need Assessment in OIC Member Countries

Preparing for Pandemic Influenza Anna Lönnroth European Commission DG Research: Health Research Priority Medicines for Europe and the World.

HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,

Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.

Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.

Developing a vaccine and how a pandemic could occur.

Introduction to Impact Evaluation: What is it and why do we use it? Male Circumcision Impact Evaluation Meeting Johannesburg, South Africa January 18-23,

Philadelphia Actuaries Club Pandemics – Past, Present and Future Presented by Annemarie Brownmiller Consulting Services of Princeton, LLC 19 November 2009.

1 ECONOMIC IMPACTS OF A PANDEMIC Dr. Mike Walden Reynolds Distinguished Professor & Extension Economist North Carolina State University.

Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.

Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,

Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.

Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.

Pandemic Influenza; A Harbinger of Things to Come Michael T Osterholm PhD, MPH Director, Center for Infectious Disease Research and Policy Associate Director,

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.

Perspectives on the Sharing of Research Materials and Data Reid Adler Founder and Principal, Practical Innovation Strategy Washington, DC Presentation.

1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.

April 25, 2009 Mexico Shuts Some Schools Amid Deadly Flu Outbreak Mexico’s flu season is usually over by now, but health officials have noticed a significant.

HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.

THE COMMONWEALTH FUND “Science” of Pandemic Influenza Stephen C. Schoenbaum, MD, MPH Executive Vice President for Programs June 15,

1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.

Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.

World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.

Food and Drug Administration

Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.

U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”

What do you need to know? Are you at risk? How do you protect yourself? SWINE FLU Partnership for Environmental Education and Rural Health peer.tamu.edu.

Avian Influenza When avian influenza hits will science have an efficient vaccine?

A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.

Response to Influenza (H1N1) 2009 in Thailand Dr. Unchalee Siripitayakunkit NVCO, DDC, MoPH 3 rd NIC meeting Yuyang Hotel, Beijing August 19, 2009.

The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.

Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.

UNDP Programming for Avian Influenza. What is the UN doing?

DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider.

Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.

Outcome On completion of this unit the student should be able to describe and evaluate programs implemented by international and Australian government.

The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.

HEALTH FORUM GASTEIN Crisis management and health policy for SARS and influenza control EUROPEAN UNION COOPERATION ON SARS CONTROL George Gouvras Health.

Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,

Advisory Forum, November 2005 ECDC and European Pandemic preparedness and Avian Influenza (H5N1) Angus Nicoll SNE Influenza Activities Coordinator.

ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.

Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.

PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.

Overview of the Objectives, Expected Outcomes, and Meeting Agenda

ECONOMIC IMPACTS OF A PANDEMIC

ECONOMIC IMPACTS OF A PANDEMIC

Expert Panel: Todd Damrow Cheryl Juntunen Susan Keady Michael Skeels

World Health Organization

The Role of NICs in Influenza Surveillance

Influenza Pandemic: A Threats to Regional and National Health and Development CSRU, SEARD.

Professor of Health Economics

Finnian Hanrahan Infectious diseases and public health

Wisconsin Free & Charitable Clinic Meeting

Presentation transcript:

Unmitigated Prejudice or Simple Negligence? The impact of biomedicine and EBM on pandemic influenza public policy Pharmaceuticals and Global Health: Inequalities and Innovation in the 21 st Century University of Sussex, 19 July 2013 Centre for International Security Studies Dr Adam Kamradt-Scott

Prejudice or Negligence: EBM & flu policy ›I am not a conspiracy theorist (!) ›Research originally funded by ERC (Ideas Grant ) to examine how different arguments, ideas and belief structures shape pandemic influenza public policy ›“The politics of medicine and the global governance of pandemic influenza” International Journal of Health Services, 43(1): Important clarifications, disclaimers & acknowledgements… 2

Prejudice or Negligence: EBM & flu policy ›World Influenza Centre established in London in 1947 ›Global Influenza Surveillance Network established in 1952 with 40 laboratories (NICs) but by 1977 = 98 NICS in 70 countries ›Renamed “Global Influenza Surveillance and Response System” in 2011 following PIPF ›Currently 141 NICs including 6 WHO CCs (as of 10 June 2013). A short history of flu governance… 3

Prejudice or Negligence: EBM & flu policy ›Post-1918, causal agent believed to be bacteria ›Influenza virus discovered in 1933 by Smith, Andrewes & Laidlaw ›Experimentation with vaccines initially led by military scientists, but picked up by civilian authorities who initiated a number of clinical trials to assess efficacy ›In 1952, vaccines were “still, in the opinion of the [WHO Expert Influenza] committee, an experimental procedure” ›By 1959, the WHO Expert Committee on Respiratory Viruses concluded “Experience in many countries has now established vaccination as the most efficient method for the prevention of influenza”. Pharmaceuticals in Pandemic Flu Public Policy 4

Prejudice or Negligence: EBM & flu policy ›Pharmacological arsenal added to in 1960s with advent of antiviral medications, but vaccines “cornerstone” of pandemic preparedness ›1997 H5N1 outbreak in Hong Kong increases global anxiety of new “overdue” pandemic, but WHO influenza personnel = 1 staff member ›1999 WHO releases pandemic guidelines, updated in 2005 and 2009 (beside topic-specific guidelines) ›By 2005 and ‘Bird Flu’ crisis all leading governance institutions (WHO, UNSIC, World Bank, IMF, etc) were advocating vaccines & antivirals as 1 st line of defence ›By 2006 securitization & EBM = ‘perfect storm’ for inadequate global supply. Pharmaceuticals in Pandemic Flu Public Policy 5

Prejudice or Negligence: EBM & flu policy ›According to WHO, global vaccine production capacity increased from 500 million doses in 2006 to almost 1 billion by 2010, nonetheless significant global shortfalls ›Focus on “evidence” preferences pharmaceutical interventions over non-pharmaceutical as more readily assessed (e.g. RCTs) ›Other potential pharmaceutical interventions are downplayed or derided (statins, elderberry extract, etc) ›No incentive for pharmaceutical companies to initiate clinical trials of statins as off-patent and already widespread generic production ›Even new universal flu vaccine will be unlikely to address global shortfall or affordability. Is there really anything wrong with this picture though? 6

Prejudice or Negligence: EBM & flu policy ›Not to suggest that the desire for “evidence” is wrong, but it is not, in itself, the answer to every problem ›A re-balancing is required to obtain evidence on effectiveness of non-pharmaceutical interventions ›Political pressure will be needed to investigate non- antiviral options (e.g. statins) ›Questions? ›Thank you. Is there really anything wrong with this picture though? 7